As mentioned above, there is some evidence that PGE2 inhibits the development of hepatic fibrosis, while other studies have shown that COX-2-dependent prostaglandins promote the development of NASH and cirrhosis (27–31). Here, PTGS2 is linked to Hepatic fibrosis.